Dr Oliver Hulson, consultant radiologist at Leeds Teaching Hospitals NHS Trust (LTHT) who is leading the trial in Leeds (Credit: LTHT)
An AI-powered service for prostate cancer which can spot lesions in minutes will…
Continue Reading
Kevin Coady, Business Leader for Disease Management Solutions & Digital Pathology at Philips North America
Understanding Prostate Cancer: Not All Are the Same
Prostate cancer is the second most common cancer in men, but what many…
Continue Reading
What You Should Know:
– Oatmeal Health and Coreline Soft, a publicly traded leader in AI imaging from South Korea and the U.S., have partnered to co-develop and distribute AI-powered lung cancer screening solutions across…
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based…
Continue Reading
An AI-powered tool designed for prostate cancer detection, QP-Prostate by Quibim, has been selected for rollout across seven NHS hospitals in England.
This two-year initiative, announced on July 9, 2025, aims to enhance early diagnosis…
Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its…
Continue Reading
Federated learning (FL) is advancing cancer research by enabling privacy-preserving collaborative training of machine learning (ML) models on diverse, multi-centre data. This systematic review synthesises current knowledge on state-of-the-art FL in oncology, focusing on…
Continue Reading
Former President Joe Biden and his family announced on May 18 that he had been diagnosed with an “more aggressive form” of Stage 4 prostate cancer, which has metastasized to his bones.The diagnosis is…
Continue Reading
